1. Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain
- Author
-
Ariana Ortuzar, María Laura Fox, Juan Antonio Vera, Álvaro Lorenzo Vizcaya, Alberto Marín Sánchez, Inmaculada Llopis Calatayud, Sara Carbonell, Alberto Álvarez-Larrán, Raquel Mata Serna, Josefa E. Marco Buades, Keina Quiroz Cervantes, Ángela Martínez Hellín, Alejandra Blum Domínguez, Gonzalo Caballero Navarro, Amparo Cáceres Sansaloni, Lucía Guerrero Fernández, Cristina Muñoz Linares, Mercedes Gasior Kabat, Raúl Pérez López, Ángeles Fernández Rodríguez, Cristina Martínez Bilbao, María Teresa Cobo Rodríguez, Álvaro Díaz, M. Antonia Durán, Marta Santaliestra Tomas, Valentín García-Gutierrez, Elena Magro Mazo, Juan Carlos Hernández-Boluda, Adrián Segura, José María Raya, Begoña Navas Elorza, and Santiago Osorio
- Subjects
Myeloproliferative Disorders ,SARS-CoV-2 ,Follow-up ,COVID-19 ,Patient satisfaction ,Hematology ,General Medicine ,Telemedicine ,Spain ,Primary Myelofibrosis ,Ph-MPN ,Humans ,Pandemics ,Polycythemia Vera ,Aged ,Retrospective Studies ,Thrombocythemia, Essential - Abstract
The SARS-CoV-2 pandemic has favored the expansion of telemedicine. Philadelphia-negative chronic myeloproliferative neoplasms (Ph-MPN) might be good candidates for virtual follow-up. In this study, we aimed to analyze the follow-up of patients with Ph-MPN in Spain during COVID-19, its effectiveness, and acceptance among patients. We present a multicenter retrospective study from 30 centers. Five hundred forty-one patients were included with a median age of 67 years (yr). With a median follow-up of 19 months, 4410 appointments were recorded. The median of visits per patient was 7 and median periodicity was 2.7 months; significantly more visits and a higher frequency of them were registered in myelofibrosis (MF) patients. 60.1% of visits were in-person, 39.5% were by telephone, and 0.3% were videocall visits, with a predominance of telephone visits for essential thrombocythemia (ET) and polycythemia vera (PV) patients over MF, as well as for younger patients ( 50 yr). The proportion of phone visits significantly decreased after the first semester of the pandemic. Pharmacological modifications were performed only in 25.7% of the visits, and, considering overall management, ET patients needed fewer global treatment changes. Telephone contact effectiveness reached 90% and only 5.4% required a complementary in-person appointment. Although 56.2% of the cohort preferred in-person visits, 90.5% of our patients claimed to be satisfied with follow-up during the pandemic, with an 83% of positive comments. In view of our results, telemedicine has proven effective and efficient, and might continue to play a complementary role in Ph-MPN patients' follow-up.
- Published
- 2022